DGAP-PVR: Probiodrug AG: Release according to Article 26,

Probiodrug AG 13.11.2015 17:00 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Probiodrug AG Halle (Saale), Germany Handelsregister: Amtsgericht Stendal, HRB 213719 (Commercial Register: Local Court of Stendal, HRB 213719) ISIN: DE0007921835 Release pursuant to Article 26 Section 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act) with the objective of Europe-wide distribution Dissemination of notifications of voting rights pursuant to sec. 21 para. 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act) 1. Biotech Growth N.V., Willemstad, Curacao, the Netherlands Antilles (Dutch Caribbean), informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 10, 2015, that its voting rights proportion fell below the threshold of 15% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 9, 2015, and that its voting rights proportion in Probiodrug AG amounted to 14.12% (corresponding to 1,050,784 voting rights) on that date. 2. BB Biotech AG, Schaffhausen, Switzerland, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 10, 2015, that its voting rights proportion fell below the threshold of 15% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 9, 2015, and that its voting rights proportion in Probiodrug AG amounted to 14.12% (corresponding to 1,050,784 voting rights) on that date. 14.12% (corresponding to 1,050,784 voting rights) are to be attributed to BB Biotech AG pursuant to sec. 22 para. 1 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to BB Biotech AG are held via the following controlled companies whose holdings of voting rights amount to 3% or more in Probiodrug AG: Biotech Growth N.V. 3. Kempen & Co N.V., Amsterdam, the Netherlands, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12, 2015, that its voting rights proportion exceeded the thresholds of 3% and 5% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 9, 2015, and that its voting rights proportion in Probiodrug AG amounted to 9.09% (corresponding to 676,589 voting rights) on that date. 4. F. van Lanschot Bankiers N.V., 's-Hertogenbosch, the Netherlands, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12, 2015, that its voting rights proportion exceeded the thresholds of 3% and 5% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 9, 2015, and that its voting rights proportion in Probiodrug AG amounted to 9.09% (corresponding to 676,589 voting rights) on that date. 9.09% (corresponding to 676,589 voting rights) are to be attributed to F. van Lanschot Bankiers N.V. pursuant to sec. 22 para. 1 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to F. van Lanschot Bankiers N.V. are held via the following controlled companies whose holdings of voting rights amount to 3% or more in Probiodrug AG: Kempen & Co N.V. 5. Van Lanschot N.V., 's-Hertogenbosch, the Netherlands, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12, 2015, that its voting rights proportion exceeded the thresholds of 3% and 5% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 9, 2015, and that its voting rights proportion in Probiodrug AG amounted to 9.09% (corresponding to 676,589 voting rights) on that date. 9.09% (corresponding to 676,589 voting rights) are to be attributed to Van Lanschot N.V. pursuant to sec. 22 para. 1 sentence 1 no. 1 WpHG. The voting rights that are to be attributed to Van Lanschot N.V. are held via the following controlled companies whose holdings of voting rights amount to 3% or more in Probiodrug AG: F. van Lanschot Bankiers N.V.; Kempen & Co N.V. 6. Kempen & Co N.V., Amsterdam, the Netherlands, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12, 2015, that its voting rights proportion fell below the thresholds of 5% and 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 10, 2015, and that its voting rights proportion in Probiodrug AG amounted to 0.00% (corresponding to 0 voting rights) on that date. 7. F. van Lanschot Bankiers N.V., 's-Hertogenbosch, the Netherlands, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12, 2015, that its voting rights proportion fell below the thresholds of 5% and 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 10, 2015, and that its voting rights proportion in Probiodrug AG amounted to 0.00% (corresponding to 0 voting rights) on that date. 8. Van Lanschot N.V., 's-Hertogenbosch, the Netherlands, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12, 2015, that its voting rights proportion fell below the thresholds of 5% and 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 10, 2015, and that its voting rights proportion in Probiodrug AG amounted to 0.00% (corresponding to 0 voting rights) on that date. Halle (Saale), in November 2015 The Management 13.11.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------